Business Context and Reporting Period
Company: GlaxoSmithKline plc
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: May 2014 (Event date: May 08, 2014)
This filing reports a corporate governance update regarding the Board of Directors rather than financial results.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notice of a board committee change and contains no financial data.
Material Changes
Board Committee Change: Judy Lewent, a Non-Executive Director, has been appointed as a member of the Nominations Committee effective May 08, 2014.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Judy Lewent's appointment to the Nominations Committee is effective as of May 08, 2014.
- This filing does not contain financial performance data; investors should refer to the company's Form 20-F or quarterly earnings releases for financial metrics.
- The registrant files annual reports under Form 20-F.